Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapeutics symbols : BNPQY save search
Vico Therapeutics Announces $60 million (€54 million) Series B Financing to Advance VO659 Clinical-Stage Program for Rare Neurological Diseases and Expand Pipeline
Published: 2024-01-05 (Crawled : 07:00) - prnewswire.com
BNPQF | News | $70.45 -13.4% 1.8K
|
Finance
|
| O: 0.0%
H: 0.0%
C: -0.2%
BNPQY | News | $36.46 -2.68% 91K
|
Finance and Insurance
|
| O: -0.03%
H: 1.19%
C: 0.64%
vo659 rare million pipeline series neurological program therapeutics
Concarlo Therapeutics Hires Vadim Shepel as Chief Business & Operating Officer, Completing Build-out of Company's Core Executive Team
Published: 2022-07-27 (Crawled : 13:20) - biospace.com/
BNPQF | News | $70.45 -13.4% 1.8K
|
Finance
|
| O: 0.0%
H: 0.0%
C: -5.21%
BNPQY | News | $36.46 -2.68% 91K
|
Finance and Insurance
|
| O: 0.67%
H: 2.32%
C: 2.18%
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.78%
H: 0.57%
C: -0.01%
therapeutics
Neurophth Therapeutics Strengthens Leadership Team with Appointment of Su Zhang as Chief Financial Officer
Published: 2021-11-24 (Crawled : 14:00) - biospace.com/
BNPQF | News | $70.45 -13.4% 1.8K
|
Finance
|
| O: -0.73%
H: 0.0%
C: -0.55%
BNPQY | News | $36.46 -2.68% 91K
|
Finance and Insurance
|
| O: -1.5%
H: 0.79%
C: 0.15%
therapeutics
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.